Glipizide and Salivary hypersecretion - from FDA reports


Salivary hypersecretion is found among people who take Glipizide, especially for people who are male, 60+ old also take medication Byetta, and have High blood pressure. This review analyzes which people have Salivary hypersecretion with Glipizide. It is created by eHealthMe based on reports of 36,619 people who have side effects when taking Glipizide from FDA , and is updated regularly.

What to expect?

If you take Glipizide and have Salivary hypersecretion, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Glipizide and have Salivary hypersecretion

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 11, 2017

36,619 people reported to have side effects when taking Glipizide.
Among them, 10 people (0.03%) have Salivary hypersecretion

Number of reports submitted per year:

Could Glipizide cause Salivary hypersecretion?

Gender of people who have Salivary hypersecretion when taking Glipizide *:

  • female: 50 %
  • male: 50 %

Age of people who have Salivary hypersecretion when taking Glipizide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.11 %
  • 40-49: 22.22 %
  • 50-59: 11.11 %
  • 60+: 55.56 %

Top conditions involved for these people *:

  • Multiple Myeloma (1 person, 10.00%)
  • High Blood Pressure (1 person, 10.00%)

Top co-used drugs for these people *:

  • Byetta (3 people, 30.00%)
  • Lipitor (2 people, 20.00%)
  • Metformin (1 person, 10.00%)
  • Eliquis (1 person, 10.00%)
  • Clozaril (1 person, 10.00%)

Top other side effects for these people *:

  • Weight Decreased (2 people, 20.00%)
  • Weakness (2 people, 20.00%)
  • Swallowing Difficulty (2 people, 20.00%)
  • Breathing Difficulty (2 people, 20.00%)
  • Appetite - Decreased (2 people, 20.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Salivary hypersecretion when taking Glipizide?

Expand the study to include all drugs with the same ingredients

Salivary hypersecretion and drugs with ingredients of glipizide.

Expand the study to include reports from both FDA and eHealthMe

Salivary hypersecretion and Glipizide from FDA and eHealthMe reports


Glipizide has active ingredients of glipizide. It is often used in diabetes. (latest outcomes from Glipizide 37,470 users)

Salivary hypersecretion

Salivary hypersecretion (excess saliva secretion) has been reported by people with schizophrenia, depression, high blood pressure, schizophrenia, paranoid type, high blood cholesterol (latest reports from 7,511 Salivary hypersecretion patients).

Browse all side effects of Glipizide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Salivary hypersecretion

Salivary hypersecretion

Could your condition cause Salivary hypersecretion

Salivary hypersecretion

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Glipizide and have Salivary hypersecretion.

Questions to the study

More questions >

User reviews to the study

More reviews >